Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Clozapine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma 1 Leukemia 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1

Interventions

Cyclophosphamide 313 Cytarabine 252 fludarabine phosphate 173 Methotrexate 155 Filgrastim 137 Busulfan 125 Etoposide 124 fludarabine 113 Rituximab 110 Peripheral Blood Stem Cell Transplantation 105 Radiotherapy 98 Vincristine 91 Daunorubicin 83 Cyclosporine 83 Antilymphocyte Serum 81 Dexamethasone 80 Melphalan 74 Whole-Body Irradiation 72 Mycophenolic Acid 71 Tacrolimus 68 Imatinib Mesylate 62 Idarubicin 62 Mercaptopurine 58 Azacitidine 56 Methylprednisolone 52 Doxorubicin 52 Granulocyte Colony-Stimulating Factor 51 Prednisone 50 Clofarabine 47 Mitoxantrone 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡